Blinatumomab Maintenance Following Allogeneic Hematopoietic Cell Transplantation for Patients With Acute Lymphoblastic Leukemia
Clinical trial NCT02807883 · COMPLETED
Trial details
- NCT number
- NCT02807883
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-01
- Primary completion
- 2022-02-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.